Immutep
IMMP
4 hedge funds and large institutions have $74K invested in Immutep in 2013 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, reducing their positions, and 2 closing their positions.
1,782% more capital inflows, than outflows
Capital inflows: $151K | Capital outflows: $8K
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
33% more funds holding
Funds holding: 3 → 4 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$40.6K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$22.6K |
| 3 |
UBS
Zurich,
Switzerland
|
+$7.02K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
-$6K |
| 2 |
Tower Research Capital (TRC)
New York
|
-$2K |
IMMP Hedge Fund Activity: Q3 2013 in Review
4 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in Immutep (IMMP) for Q3 2013, worth a combined $74K — up 573% from $11K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new IMMP positions and 2 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Morgan Stanley, opening a new position worth an estimated $40.6K. The largest seller was Citigroup, exiting entirely with an estimated $6K sold.
- 4 institutional investors held Immutep (IMMP) as of Q3 2013, up from 3 in Q2 2013.
- Funds reported $74K of Immutep stock for Q3 2013, up 573% quarter-over-quarter.
- 3 funds opened new Immutep positions in Q3 2013 and 2 closed out, a net change of +1 holder.
- The largest Immutep buyer in Q3 2013 was Morgan Stanley, an estimated $40.6K added.
- The largest Immutep seller in Q3 2013 was Citigroup, an estimated $6K sold.
Based on aggregated 13F filings for Q3 2013.